Global Partnership Launches Affordable HIV Prevention to End Epidemic
Cheap supplies of the groundbreaking HIV prevention injection lenacapavir will be available in many poorer countries from 2027 at $40 per patient per year, potentially transforming efforts to end the global HIV epidemic, with support from major health organizations and generic drug manufacturers.